Population Genetics
PGT is now focusing its business on licensing its compelling intellectual properties to leading companies in the infectious disease molecular diagnostic and broader sequencing and life science tools sectors that have the capabilities and resources to bring our technologies to market and through, where needed, the required regulatory approval. To complement this focus, PGT is developing collaborations with high profile research groups, primarily in academia and non-profit institutions to provide further validation and application of the core PGT intellectual property (and thus enhancing its value).